US Patent Issued to Recursion Pharmaceuticals on Nov. 4 for "Utilizing compound-protein machine learning representations to generate bioactivity predictions" (Canadian Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,462,903, issued on Nov. 4, was assigned to Recursion Pharmaceuticals Inc. (Salt Lake City).

"Utilizing compound-protein machine learning representations to generate bioactivity predictions" was invented by Seyed Ali Madani Tonekaboni (Toronto), Daniella Fiora Lato (Toronto) and Stephen Scott MacKinnon (Burlington, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to systems, non-transitory computer-readable media, and methods that utilizing compound-protein machine learning representations to generate target results. For example, the disclosed systems can utilize a compound-protein interaction machine learning model to ...